Human gene therapy is a more recent development spurred by the successful treatment, in September 1990, of a patient in the United States with a gene modified cell therapy for severe combined immunodeficiency (SCID) due to adenosine deaminase deficiency (8). The gene discussed is ADA; the disease is severe combined immunodeficiency.